Physician profile
Lisa E Batchelor
NPI 1013072859
$4,610.23
in general payments reported to CMS, 2019-2025
17 companies · $2,938 in 2025
The $2,938 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $24.88 · 2022: $44.16 · 2023: $240 · 2024: $1,363 · 2025: $2,938.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,541.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $1,580.43 | 2023-2025 | Yeztugo, Descovy, Epclusa |
| Viiv Healthcare Company | $730.50 | 2024-2025 | Cabenuva, Apretude |
| Janssen Pharmaceuticals, INC | $449.41 | 2025 | Invega Sustenna, Invega Trinza |
| Abbvie INC. | $295.00 | 2021-2025 | |
| Braeburn INC. | $255.67 | 2024-2025 | Brixadi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $142.45 | 2025 | Caplyta |
| Genzyme Corporation | $142.45 | 2024 | |
| Madrigal Pharmaceuticals | $135.11 | 2025 | Rezdiffra |
| Hologic Sales and Service, LLC | $126.82 | 2023 | Aptima |
| Napo Pharmaceuticals INC | $124.99 | 2024 | Mytesi |
| Glaxosmithkline, LLC. | $122.06 | 2025 | Shingrix |
| Emd Serono, INC. | $121.83 | 2024 | Serostim |
| Janssen Biotech, INC. | $121.39 | 2025 | Rybrevant, Carvykti |
| Stryker Corporation | $108.93 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Astellas Pharma US INC | $99.65 | 2025 | Vyloy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $31.00 | 2025 | Lybalvi |
| Eisai INC. | $22.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Batchelor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.